Misonidazole as a chemosensitizer in the treatment of the dunning prostage cancer model

Ralph W deVere White, N. A. Romas, P. Tomashefsky, E. J. Hall, C. A. Olsson

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Utilizing a Dunning prostate tumor model, we investigated the ability of misonidazole, a compound with known radiosensitizing properties, to act as a chemosensitizer when administered in combination with the alkylating agent cyclophosphamide. This combination caused a decrease in tumor growth rate when compared to the growth of the tumor in animals receiving cyclophosphamide alone. However, only at toxic levels was this decrease statistically significant (p < 0.01).

Original languageEnglish (US)
Pages (from-to)374-377
Number of pages4
JournalJournal of Urology
Volume131
Issue number2
StatePublished - 1984
Externally publishedYes

Fingerprint

Misonidazole
Cyclophosphamide
Neoplasms
Poisons
Alkylating Agents
Growth
Prostate

ASJC Scopus subject areas

  • Urology

Cite this

deVere White, R. W., Romas, N. A., Tomashefsky, P., Hall, E. J., & Olsson, C. A. (1984). Misonidazole as a chemosensitizer in the treatment of the dunning prostage cancer model. Journal of Urology, 131(2), 374-377.

Misonidazole as a chemosensitizer in the treatment of the dunning prostage cancer model. / deVere White, Ralph W; Romas, N. A.; Tomashefsky, P.; Hall, E. J.; Olsson, C. A.

In: Journal of Urology, Vol. 131, No. 2, 1984, p. 374-377.

Research output: Contribution to journalArticle

deVere White, RW, Romas, NA, Tomashefsky, P, Hall, EJ & Olsson, CA 1984, 'Misonidazole as a chemosensitizer in the treatment of the dunning prostage cancer model', Journal of Urology, vol. 131, no. 2, pp. 374-377.
deVere White, Ralph W ; Romas, N. A. ; Tomashefsky, P. ; Hall, E. J. ; Olsson, C. A. / Misonidazole as a chemosensitizer in the treatment of the dunning prostage cancer model. In: Journal of Urology. 1984 ; Vol. 131, No. 2. pp. 374-377.
@article{74c494d1a25c446bbcd8ef74c1e63281,
title = "Misonidazole as a chemosensitizer in the treatment of the dunning prostage cancer model",
abstract = "Utilizing a Dunning prostate tumor model, we investigated the ability of misonidazole, a compound with known radiosensitizing properties, to act as a chemosensitizer when administered in combination with the alkylating agent cyclophosphamide. This combination caused a decrease in tumor growth rate when compared to the growth of the tumor in animals receiving cyclophosphamide alone. However, only at toxic levels was this decrease statistically significant (p < 0.01).",
author = "{deVere White}, {Ralph W} and Romas, {N. A.} and P. Tomashefsky and Hall, {E. J.} and Olsson, {C. A.}",
year = "1984",
language = "English (US)",
volume = "131",
pages = "374--377",
journal = "Journal of Urology",
issn = "0022-5347",
publisher = "Elsevier Inc.",
number = "2",

}

TY - JOUR

T1 - Misonidazole as a chemosensitizer in the treatment of the dunning prostage cancer model

AU - deVere White, Ralph W

AU - Romas, N. A.

AU - Tomashefsky, P.

AU - Hall, E. J.

AU - Olsson, C. A.

PY - 1984

Y1 - 1984

N2 - Utilizing a Dunning prostate tumor model, we investigated the ability of misonidazole, a compound with known radiosensitizing properties, to act as a chemosensitizer when administered in combination with the alkylating agent cyclophosphamide. This combination caused a decrease in tumor growth rate when compared to the growth of the tumor in animals receiving cyclophosphamide alone. However, only at toxic levels was this decrease statistically significant (p < 0.01).

AB - Utilizing a Dunning prostate tumor model, we investigated the ability of misonidazole, a compound with known radiosensitizing properties, to act as a chemosensitizer when administered in combination with the alkylating agent cyclophosphamide. This combination caused a decrease in tumor growth rate when compared to the growth of the tumor in animals receiving cyclophosphamide alone. However, only at toxic levels was this decrease statistically significant (p < 0.01).

UR - http://www.scopus.com/inward/record.url?scp=0021326690&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0021326690&partnerID=8YFLogxK

M3 - Article

C2 - 6699977

AN - SCOPUS:0021326690

VL - 131

SP - 374

EP - 377

JO - Journal of Urology

JF - Journal of Urology

SN - 0022-5347

IS - 2

ER -